ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Osteoarthritis

Osteoarthritis

Osteoporosis (©JavierRegueiro/Shutterstock.com)

For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. In this slideshow, we highlight the new guidelines.

(©sfamphoto/Shutterstock.com)

The severity of long-term chronic pain that impedes daily life seems to be associated with higher mortality, researchers report.

(©NisakornNeera/Shutterstock.com)

Study comparing pharmaceutical-grade chondroitin sulfate to celecoxib for knee osteoarthritis shows similar rates of pain relief.

(Injection of a vaccine  ©thodonal88/Shutterstock.com)

Vaccine efficacy in RA, biosimilar safety and the danger of steroid injections for knee osteoarthritis top this week's research roundup. In this slideshow, we feature these and other recent research findings from the key journals.

Knee OA (©PuwadolJaturawutthichai/Shutterstock.com)

Despite monthly dosing regimen and long half-life of fulranumab, patients experienced pain relief within a short period of time.

Naproxen Pollapat (©Chirawong/Shutterstock.com)

Celecoxib is preferred over naproxen for arthritis patients at high risk for cardiovascular and gastrointestinal events, researchers report.

(©DmitryKalinovsky/Shutterstock.com)

In this slideshow, we offer a glance at newly approved treatments for rheumatoid arthritis, juvenile arthritis, osteoporosis and fingernail psoriasis, among other conditions.

Pages

Subscribe to Osteoarthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.